NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 208 filers reported holding NOVAVAX INC in Q1 2024. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $214 | -3.6% | 45,000 | 0.0% | 0.00% | – |
| Q4 2023 | $222 | -31.1% | 45,000 | 0.0% | 0.00% | -100.0% |
| Q3 2023 | $322 | +40.0% | 45,000 | +88.3% | 0.00% | 0.0% |
| Q4 2022 | $230 | -100.0% | 23,900 | -7.5% | 0.00% | 0.0% |
| Q3 2022 | $476,000 | -63.3% | 25,850 | 0.0% | 0.00% | -75.0% |
| Q2 2022 | $1,297,000 | -56.7% | 25,850 | -34.7% | 0.00% | -42.9% |
| Q1 2022 | $2,997,000 | -45.1% | 39,595 | +10.1% | 0.01% | -46.2% |
| Q4 2021 | $5,458,000 | -26.4% | 35,968 | -0.3% | 0.01% | -38.1% |
| Q3 2021 | $7,416,000 | +19.7% | 36,073 | +21.7% | 0.02% | +16.7% |
| Q2 2021 | $6,197,000 | +77.4% | 29,641 | +48.2% | 0.02% | +50.0% |
| Q1 2021 | $3,493,000 | +46.3% | 20,000 | 0.0% | 0.01% | +33.3% |
| Q4 2020 | $2,388,000 | +3751.6% | 20,000 | +97.8% | 0.01% | – |
| Q2 2019 | $62,000 | – | 10,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 493,650 | $55,047,000 | 6.79% |
| RA Capital Management | 3,788,564 | $422,463,000 | 5.91% |
| Foresite Capital Management I, LLC | 66,810 | $7,450,000 | 3.92% |
| HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 10,000 | $1,115,000 | 3.54% |
| TSP Capital Management Group, LLC | 50,075 | $5,584,000 | 1.98% |
| Foresite Capital Management II, LLC | 67,373 | $7,513,000 | 1.98% |
| Healthcare Value Capital, LLC | 5,000 | $558,000 | 1.88% |
| SECTORAL ASSET MANAGEMENT INC | 223,350 | $24,906,000 | 1.76% |
| WBI INVESTMENTS, LLC | 96,619 | $10,774,000 | 1.63% |
| Ikarian Capital, LLC | 323,700 | $36,097,000 | 1.59% |